Western blot results showed that the high expression levels of FAP1, S100A4, vimentin, α-SMA, and collagen I and III induced by BLM were substantially repressed by C-PC treatment (Fig. 2H). The gene discussed is PTPN13; the disease is Bloom syndrome.